What Eikon Therapeutics, Inc.'s executives and directors are doing with their own shares, from SEC Form 3/4/5 filings — separating what the filings state (awards, withholding, disclosed plans) from what only the pattern of dates shows.
| 3 months | 12 months | |
|---|---|---|
| Open-market buys | 0 | 9 |
| Sells | 0 | 0 |
| Total trades | 0 | 37 |
| 3 months | 12 months | |
|---|---|---|
| Acquired | 0 | 22,151,882 |
| Disposed | 0 | 0 |
| Net activity | +0 | +22,151,882 |
View rich charts and dive into the patterns of specific insiders — who is accumulating, who is winding down, and which sale explanations the filings actually support.
| Insider | Relation | Date | Transaction | Shares | Price | Value | Shares held |
|---|---|---|---|---|---|---|---|
| Lux Venture Partners V, Llc | 10% owner | Feb 06 | Derivative Conversion · C | +2,155,765 | — | — | 2,294,653 |
| Lux Venture Partners V, Llc | 10% owner | Feb 06 | Derivative Conversion · C | +1,151,540 | — | — | 1,290,428 |
| Lux Venture Partners V, Llc | 10% owner | Feb 06 | Derivative Conversion · C | +2,387,705 | — | — | 2,387,705 |
| Wolfe Josh | Director | Feb 06 | Derivative Conversion · C | +2,155,765 | — | — | 2,294,653 |
| Wolfe Josh | Director | Feb 06 | Derivative Conversion · C | +1,151,540 | — | — | 1,290,428 |
| Wolfe Josh | Director | Feb 06 | Derivative Conversion · C | +2,387,705 | — | — | 2,387,705 |
| Column Group Iv GP, Lp | 10% owner | Feb 06 | Open-market buy · P | +630,881 | $18.00 | +$11.4M | 1,319,164 |
| Column Group Iv GP, Lp | 10% owner | Feb 06 | Open-market buy · P | +49,556 | $18.00 | +$892K | 148,840 |
| Column Group Iv GP, Lp | 10% owner | Feb 06 | Open-market buy · P | +1,437,323 | $18.00 | +$25.9M | 4,312,139 |
| Column Group Iv GP, Lp | 10% owner | Feb 06 | Derivative Conversion · C | +688,283 | — | — | 688,283 |
| Column Group Iv GP, Lp | 10% owner | Feb 06 | Derivative Conversion · C | +3,785 | — | — | 99,284 |
| Column Group Iv GP, Lp | 10% owner | Feb 06 | Derivative Conversion · C | +47,898 | — | — | 95,499 |
| Column Group Iv GP, Lp | 10% owner | Feb 06 | Derivative Conversion · C | +44,249 | — | — | 47,601 |
| Column Group Iv GP, Lp | 10% owner | Feb 06 | Derivative Conversion · C | +110,928 | — | — | 2,874,816 |
| Column Group Iv GP, Lp | 10% owner | Feb 06 | Derivative Conversion · C | +1,403,568 | — | — | 2,763,888 |
| Column Group Iv GP, Lp | 10% owner | Feb 06 | Derivative Conversion · C | +1,296,629 | — | — | 1,360,320 |
| Perlmutter Roger M | See remarks | Feb 06 | Derivative Conversion · C | +284,857 | — | — | 284,857 |
| Lux Venture Partners V, Llc | 10% owner | Feb 04 | Open-market buy · P | +138,888 | $18.00 | +$2.5M | 138,888 |
| Lux Venture Partners V, Llc | 10% owner | Feb 04 | Open-market buy · P | +138,888 | $18.00 | +$2.5M | 138,888 |
| Wolfe Josh | Director | Feb 04 | Open-market buy · P | +138,888 | $18.00 | +$2.5M | 138,888 |
Loading...